Evidence map›Paper›PMID 34069332›Full record

ArticleTropical medicine and infectious disease2021

Assessing the Impact of COVID-19 on TB and HIV Programme Services in Selected Health Facilities in Lilongwe, Malawi: Operational Research in Real Time.

Pruthu Thekkur, Hannock Tweya, Sam Phiri, James Mpunga, Thokozani Kalua, Ajay M V Kumar, Srinath Satyanarayana, Hemant D Shewade, Mohammed Khogali, Rony Zachariah and 3 more

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Lived experiences of tuberculosis patients accessing treatment during COVID-19 in Zimbabwe.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Pruthu ThekkurInternational Union Against Tuberculosis and Lung Disease (The Union), 75006 Paris, France.ORCID 0000-0001-5257-5074
Hannock TweyaThe Lighthouse, Kamuzu Central Hospital, Lilongwe P.O. Box 106, Malawi.
Sam PhiriThe Lighthouse, Kamuzu Central Hospital, Lilongwe P.O. Box 106, Malawi.ORCID 0000-0002-9372-212X
James MpungaNational Tuberculosis Programme, Ministry of Health and Population, Lilongwe P.O. Box 30377, Malawi.
Thokozani KaluaHIV/AIDS Department, Ministry of Health and Population, Lilongwe P.O. Box 30377, Malawi.
Ajay M V KumarInternational Union Against Tuberculosis and Lung Disease (The Union), 75006 Paris, France.ORCID 0000-0003-1011-8531
Srinath SatyanarayanaInternational Union Against Tuberculosis and Lung Disease (The Union), 75006 Paris, France.ORCID 0000-0002-5420-2551
Hemant D ShewadeInternational Union Against Tuberculosis and Lung Disease (The Union), 75006 Paris, France.ORCID 0000-0002-8242-1911
Mohammed KhogaliSpecial Programme for Research and Training in Tropical Disease (TDR), World Health Organization, 1211 Geneva, Switzerland.
Rony ZachariahSpecial Programme for Research and Training in Tropical Disease (TDR), World Health Organization, 1211 Geneva, Switzerland.ORCID 0000-0002-2915-9328
I D RusenVital Strategies, New York, NY 10005, USA.
Selma Dar BergerInternational Union Against Tuberculosis and Lung Disease (The Union), 75006 Paris, France.
Anthony D HarriesInternational Union Against Tuberculosis and Lung Disease (The Union), 75006 Paris, France.ORCID 0000-0001-6113-9741

Funding

Bloomberg Philanthropies through Vital Strategies and Resolve to Save Lives 78941World Health Organization 001
6 · The paper itself

Abstract

When the COVID-19 pandemic was announced in March 2020, there was concern that TB and HIV programme services in Malawi would be severely affected. We set up real-time monthly surveillance of TB and HIV activities in eight health facilities in Lilongwe to see if it was possible to counteract the anticipated negative impact on TB case detection and treatment and HIV testing. Aggregate data were collected monthly during the COVID-19 period (March 2020-February 2021) using an EpiCollect5 application and compared with monthly data collected during the pre-COVID-19 period (March 2019-February 2020); these reports were sent monthly to programme directors. During COVID-19, there was an overall decrease in persons presenting with presumptive pulmonary TB (45.6%), in patients registered for TB treatment (19.1%), and in individuals tested for HIV (39.0%). For presumptive TB, children and females were more affected, but for HIV testing, adults and males were more affected. During COVID-19, the TB treatment success rate (96.1% in pre-COVID-19 and 96.0% during COVID-19 period) and referral of HIV-positive persons to antiretroviral therapy (100% in pre-COVID-19 and 98.6% during COVID-19 period) remained high and largely unchanged. Declining trends in TB and HIV case detection were not redressed despite real-time monthly surveillance.

Indexed as

antiretroviral therapyCOVID-19EpiCollect5HIVLilongweMalawioperational researchpresumptive tuberculosisTB treatment outcomestuberculosis

Identifiers

PMID34069332
PMCPMC8163191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.